Evidence map›Paper›PMID 29081196›Full record

ArticleZhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi2017

[Prognostic significance of proteins expression by immunohistochemical method in diffuse large B cell lymphoma].

W J Yu, L H Cao, J H Wang, Z M Wang, W B Qian, H Y Tong, H T Meng, W Y Mai, L P Mao, J J Qian and 1 more

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

W J YuThe Department of Hematology, the First Affiliated Hospital, College of Medicine, Zhejiang Provincial Key Lab of Hematopoietic Malignancy, Zhejiang University, Hangzhou 310003, China.
L H Cao
J H Wang
Z M Wang
W B Qian
H Y Tong
H T Meng
W Y Mai
L P Mao
J J Qian
J Jin
First Affiliated Hospital Zhejiang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Lymphoma, Large B-Cell, DiffuseAntineoplastic Combined Chemotherapy ProtocolsCyclophosphamideDoxorubicinHumansMaleMiddle AgedPrognosisProto-Oncogene MasProto-Oncogene Proteins c-bcl-2Proto-Oncogene Proteins c-bcl-6Retrospective StudiesRituximabVincristineCyclophosphamideDoxorubicinMAS1 protein, humanProto-Oncogene MasProto-Oncogene Proteins c-bcl-2Proto-Oncogene Proteins c-bcl-6RituximabVincristineLymphoma, large B cell, diffusePrognosisProto-oncogene proteins c-bcl-2Proto-oncogene proteins c-mycTumor suppressor protein p53

Identifiers

PMID29081196
PMCPMC7348361
OpenAlexW3006597987

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.